Literature DB >> 8434116

Prolonged cell cycle delay in radioresistant human cell lines transfected with activated ras oncogene and/or simian virus 40 T-antigen.

L N Su1, J B Little.   

Abstract

Normal human diploid cell strains were transfected with an activated Ha-ras oncogene (EJ ras) and/or SV40 T-antigen. Clones expressing SV40 T-antigen alone or in combination with ras protein p21 were significantly radioresistant (D0 = 1.68-2.73 Gy) compared with their parent cells or clones transfected with the neo gene only (D0 = 1.20-1.35 Gy). This radioresistant phenotype persisted in postcrisis, immortalized cell lines. Cell cycle perturbations after X irradiations were studied in four immortalized, radioresistant cell lines transfected with EJ-ras plus SV40 T or SV40 T alone as well as in two nontransfected parental cell strains. Exponentially growing cells were exposed to various doses of X radiation and the distributions within the cell cycle were determined by flow cytometry. The time of onset and duration of division delay were also measured by cell counting. All cells underwent a dose-dependent G2 arrest; the duration of this division delay was proportional to radiation dose. The radioresistant cell lines had a longer arrest in G2 phase of the cell cycle compared to that of the parental cell strains. These data suggest that a prolonged cell cycle delay may be one of the factors involved in the radioresistance acquired by transfection of human diploid cells with SV40 T-antigen.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8434116

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  9 in total

1.  Combination treatment with dihydrotanshinone I and irradiation enhances apoptotic effects in human cervical cancer by HPV E6 down-regulation and caspases activation.

Authors:  Yintao Ye; Wenqing Xu; Wei Zhong; Yajing Li; Chen Wang
Journal:  Mol Cell Biochem       Date:  2011-12-07       Impact factor: 3.396

2.  Contribution of inducible and constitutive mechanisms to radioresistance acquisition by hamster malignant fibroblasts.

Authors:  E G Tyrsina; S V Slanina; E D Alipov
Journal:  Dokl Biochem Biophys       Date:  2007 May-Jun       Impact factor: 0.788

3.  A histone deacetylase inhibitor, trichostatin A, enhances radiosensitivity by abrogating G2/M arrest in human carcinoma cells.

Authors:  In Ah Kim; Jin Ho Kim; Jin Hee Shin; Il Han Kim; Jae Sung Kim; Hong-Gyun Wu; Eui Kyu Chie; Yong Ho Kim; Bo-Kyung Kim; Semie Hong; Seok Won Park; Sung Whan Ha; Charn Il Park
Journal:  Cancer Res Treat       Date:  2005-04-30       Impact factor: 4.679

4.  HRAD1 and MRAD1 encode mammalian homologues of the fission yeast rad1(+) cell cycle checkpoint control gene.

Authors:  C M Udell; S K Lee; S Davey
Journal:  Nucleic Acids Res       Date:  1998-09-01       Impact factor: 16.971

5.  Mefloquine exposure induces cell cycle delay and reveals stage-specific expression of the pfmdr1 gene.

Authors:  Elaine B Bohórquez; Jonathan J Juliano; Hyung-Suk Kim; Steven R Meshnick
Journal:  Antimicrob Agents Chemother       Date:  2012-12-03       Impact factor: 5.191

Review 6.  Cell cycle regulation in response to DNA damage in mammalian cells: a historical perspective.

Authors:  J P Murnane
Journal:  Cancer Metastasis Rev       Date:  1995-03       Impact factor: 9.264

7.  Late G1 accumulation after 2 Gy of gamma-irradiation is related to endogenous Raf-1 protein expression and intrinsic radiosensitivity in human cells.

Authors:  H M Warenius; M Jones; M D Jones; P G Browning; L A Seabra; C C Thompson
Journal:  Br J Cancer       Date:  1998-04       Impact factor: 7.640

8.  Combined RAF1 protein expression and p53 mutational status provides a strong predictor of cellular radiosensitivity.

Authors:  H M Warenius; M Jones; T Gorman; R McLeish; L Seabra; R Barraclough; P Rudland
Journal:  Br J Cancer       Date:  2000-10       Impact factor: 7.640

9.  Radiation-induced autophagy contributes to cell death and induces apoptosis partly in malignant glioma cells.

Authors:  Guk Heui Jo; Oliver Bögler; Yong-Joon Chwae; Heon Yoo; Seung Hoon Lee; Jong Bae Park; Youn-Jae Kim; Jong Heon Kim; Ho-Shin Gwak
Journal:  Cancer Res Treat       Date:  2014-08-29       Impact factor: 4.679

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.